GASTRO ESOPHAGEAL JUNCTION CANCER
Clinical trials for GASTRO ESOPHAGEAL JUNCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTRO ESOPHAGEAL JUNCTION CANCER trials appear
Sign up with your email to follow new studies for GASTRO ESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Three-Drug cocktail shrink stomach tumors before surgery?
Disease control OngoingThis phase 2 trial is testing whether adding surufatinib (a targeted therapy that blocks blood vessel growth) to standard immunotherapy and chemotherapy can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. The treatment is given befor…
Matched conditions: GASTRO ESOPHAGEAL JUNCTION CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Experimental vaccine aims to boost immune attack on Hard-to-Treat cancers
Disease control OngoingThis study tests a new genetic vaccine called Nous-209, given together with the immunotherapy drug pembrolizumab (Keytruda), in adults with advanced MSI-H or dMMR solid tumors (colorectal, gastric, or gastro-esophageal junction cancers). The vaccine is designed to train the immun…
Matched conditions: GASTRO ESOPHAGEAL JUNCTION CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nouscom SRL • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC